NEW YORK (Reuters Health) – Fenofibrate is safe to use in patients with type 2 diabetes and moderate renal impairment, researchers conclude in a report online December 30…
NEW YORK (Reuters Health) – Percutaneous nephrolithotomy (PCNL) can be safely undertaken in patients with chronic kidney disease (CKD), researchers from Turkey report in the November 17th online…
NEW YORK (Reuters Health) – Treatment with the angiotensin receptor blocker (ARB) candesartan is not associated with either carcinogenesis or cancer death compared with non-ARB standard antihypertensive treatment,…
NEW YORK (Reuters Health) – Patients undergoing hemodialysis with a dialyzer that’s sterilized by electron beam have an increased risk of thrombocytopenia, a Canadian study has shown.“Because we…
NEW YORK (Reuters Health) – Laparoscopic partial nephrectomy (LPN) and laparoscopic cryoablation (LCA) are viable nephron-sparing options for patients with a small tumor in a solitary kidney, researchers…
NEW YORK (Reuters Health) – New research supports current clinical guidance to perform partial nephrectomy (PN) when possible in patients with clinically organ-confined renal cell tumors 7 centimeters…
NEW YORK (Reuters Health) – Administering acetylcysteine to patients before and after they undergo coronary or peripheral angiography does not reduce the occurrence of contrast-induced nephropathy, according to…
NEW YORK (Reuters Health) – Beta-blockers improve all-cause mortality in patients with chronic kidney disease (CKD) and heart failure, according to a report in the September 6th Journal…
NEW YORK (Reuters Health) – A closed-loop hydration and fluid balancing system protects against contrast-induced acute kidney injury in high-risk patients, according to results of a study published…
NEW YORK (Reuters Health) – Among patients undergoing cardiac procedures, a lower dose of contrast medium based on calculated creatinine clearance may reduce the risk of contrast-induced nephropathy,…